Illumina

$279.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$9.14 (-3.17%) Today
$0.00 (0.00%) As of 4:52 PM EDT after-hours

Why Robinhood?

You can buy or sell Illumina and other stocks, options, ETFs, and crypto commission-free!

About ILMN

Illumina, Inc. engages in the development and manufacture of integrated systems for the analysis of genetic variation and function. It operates through the Core Illumina and Consolidated Variable Interest Entity segments (VIE). Read More The Core Illumina segments serve customers in the research, clinical and applied markets, and enable the adoption of genomic solutions. The Consolidated VIE segment includes activities of GRAIL and Helix. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Employees
7,300
Headquarters
San Diego, California
Founded
1998
Market Cap
41.08B
Price-Earnings Ratio
44.38
Dividend Yield
0.00
Average Volume
775.51K
High Today
$289.44
Low Today
$278.12
Open Price
$288.94
Volume
1.22M
52 Week High
$380.76
52 Week Low
$268.62

Collections

ILMN News

CNBC2h

Consumer DNA testing has hit a lull — here's how it could capture the next wave of users

7
ReutersJul 31

Edited Transcript of ILMN earnings conference call or presentation 29-Jul-19 9:00pm GMT

76
MarketWatchJul 29

Illumina stock declines after earnings, outlook

1,058

ILMN Earnings

$1.01
$1.21
$1.40
$1.60
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Oct 22, After Hours

Popular Stocks

More ILMN News

BenzingaJul 29

Q2 Earnings Preview For Illumina

377
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.